Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry: The EuroCTO (CASTLE) Score.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
25 02 2019
Historique:
received: 05 09 2018
revised: 09 10 2018
accepted: 13 11 2018
pubmed: 4 2 2019
medline: 26 3 2020
entrez: 4 2 2019
Statut: ppublish

Résumé

The aim was to establish a contemporary scoring system to predict the outcome of chronic total occlusion coronary angioplasty. Interventional treatment of chronic total coronary occlusions (CTOs) is a developing subspecialty. Predictors of technical success or failure have been derived from datasets of modest size. A robust scoring tool could facilitate case selection and inform decision making. The study analyzed data from the EuroCTO registry. This prospective database was set up in 2008 and includes >20,000 cases submitted by CTO expert operators (>50 cases/year). Derivation (n = 14,882) and validation (n = 5,745) datasets were created to develop a risk score for predicting technical failure. There were 14,882 patients in the derivation dataset (with 2,356 [15.5%] failures) and 5,745 in the validation dataset (with 703 [12.2%] failures). A total of 20.2% of cases were done retrogradely, and dissection re-entry was performed in 9.3% of cases. We identified 6 predictors of technical failure, collectively forming the CASTLE score (Coronary artery bypass graft history, Age (≥70 years), Stump anatomy [blunt or invisible], Tortuosity degree [severe or unseen], Length of occlusion [≥20 mm], and Extent of calcification [severe]). When each parameter was assigned a value of 1, technical failure was seen to increase from 8% with a CASTLE score of 0 to 1, to 35% with a score ≥4. The area under the curve (AUC) was similar in both the derivation (AUC: 0.66) and validation (AUC: 0.68) datasets. The EuroCTO (CASTLE) score is derived from the largest database of CTO cases to date and offers a useful tool for predicting procedural outcome.

Sections du résumé

OBJECTIVES
The aim was to establish a contemporary scoring system to predict the outcome of chronic total occlusion coronary angioplasty.
BACKGROUND
Interventional treatment of chronic total coronary occlusions (CTOs) is a developing subspecialty. Predictors of technical success or failure have been derived from datasets of modest size. A robust scoring tool could facilitate case selection and inform decision making.
METHODS
The study analyzed data from the EuroCTO registry. This prospective database was set up in 2008 and includes >20,000 cases submitted by CTO expert operators (>50 cases/year). Derivation (n = 14,882) and validation (n = 5,745) datasets were created to develop a risk score for predicting technical failure.
RESULTS
There were 14,882 patients in the derivation dataset (with 2,356 [15.5%] failures) and 5,745 in the validation dataset (with 703 [12.2%] failures). A total of 20.2% of cases were done retrogradely, and dissection re-entry was performed in 9.3% of cases. We identified 6 predictors of technical failure, collectively forming the CASTLE score (Coronary artery bypass graft history, Age (≥70 years), Stump anatomy [blunt or invisible], Tortuosity degree [severe or unseen], Length of occlusion [≥20 mm], and Extent of calcification [severe]). When each parameter was assigned a value of 1, technical failure was seen to increase from 8% with a CASTLE score of 0 to 1, to 35% with a score ≥4. The area under the curve (AUC) was similar in both the derivation (AUC: 0.66) and validation (AUC: 0.68) datasets.
CONCLUSIONS
The EuroCTO (CASTLE) score is derived from the largest database of CTO cases to date and offers a useful tool for predicting procedural outcome.

Identifiants

pubmed: 30711551
pii: S1936-8798(18)32310-0
doi: 10.1016/j.jcin.2018.11.020
pii:
doi:

Types de publication

Journal Article Multicenter Study Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

335-342

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Zsolt Szijgyarto (Z)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Rajiv Rampat (R)

Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, United Kingdom.

Gerald S Werner (GS)

Department of Cardiology & Intensive Care, Klinikum Darmstadt, Darmstadt, Germany.

Claudius Ho (C)

Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, United Kingdom.

Nicolaus Reifart (N)

Department of Cardiology, Main Taunus Heart Institute, Frankfurt am Main, Germany.

Thierry Lefevre (T)

Department of Cardiology, Institut Cardiovasculaire Paris Sud, Paris, France.

Yves Louvard (Y)

Department of Cardiology, Institut Cardiovasculaire Paris Sud, Paris, France.

Alexandre Avran (A)

Department of Cardiology, Arnault Tzanck Institut, Saint Laurent du Var, France.

Mashayekhi Kambis (M)

Division of Cardiology and Angiology II, University Heart Center Freiburg, Freiburg, Germany.

Heinz-Joachim Buettner (HJ)

Division of Cardiology and Angiology II, University Heart Center Freiburg, Freiburg, Germany.

Carlo Di Mario (C)

Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

Anthony Gershlick (A)

Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.

Javier Escaned (J)

Hospital Clinico San Carlos IDISSC and Complutense, Madrid, Spain.

George Sianos (G)

1st Department of Cardiology, AHEPA University Hospital, Thessaloniki, Greece.

Alfredo Galassi (A)

Department of Experimental and Clinical Medicine, University of Catania, Catania, Italy.

Roberto Garbo (R)

Interventional Cardiology Unit, San Giovanni Bosco Hospital, Torino, Italy.

Omer Goktekin (O)

Department of Cardiology, Istanbul Memorial Hospital, Istanbul, Turkey.

Marcus Meyer-Gessner (M)

Department of Cardiology, Augusta Krankenhaus, Düsseldorf, Germany.

Bernward Lauer (B)

Department of Cardiology, Kardiologie Zentralklinik, Bad Berka, Germany.

Simon Elhadad (S)

Department of Cardiology, Centre Hospitalier de Marne-la-vallée, Jossigny, France.

Alexander Bufe (A)

Helios Heart Center Krefeld, University Witten/Herdecke, Witten, Germany.

Nicolas Boudou (N)

Cardiology Department, Rangueil University Hospital, Toulouse, France.

Horst Sievert (H)

Department of Cardiology, Cardiovascular Center Frankfurt, Frankfurt am Main, Germany.

Victoria Martin-Yuste (V)

Department of Cardiology, Hospital Clínic Barcelona, Barcelona, Spain.

Leif Thuesen (L)

Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Andrejs Erglis (A)

Pauls Stradins Clinical University Hospital, University of Latvia, Riga, Latvia.

Evald Christiansen (E)

Department of Cardiology B, Aarhus University Hospital, Aarhus, Denmark.

James Spratt (J)

Department of Cardiology, St. George's University NHS Trust, London, United Kingdom.

Lesciak Bryniarski (L)

Department of Cardiology, Interventional Electrocardiology and Hypertension Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.

Tim Clayton (T)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

David Hildick-Smith (D)

Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, United Kingdom. Electronic address: david.hildick-smith@bsuh.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH